Fulton Breakefield Broenniman’s Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K C.PRK Stock Holding History
Bought
Maintained
Sold
Other funds holding C.PRK
SAM
EHC
EWM
SG
PNC
SIM
SWP
GT
Fulton Breakefield Broenniman's C.PRK Position: Q3 2019 in Review
Fulton Breakefield Broenniman sold out of Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K (C.PRK) in Q3 2019, closing a stake of 13,725 shares — an estimated $376K sold.
Fulton Breakefield Broenniman first reported a position in C.PRK in Q1 2018 and held it in 6 quarters. The position peaked at $379K in Q1 2019. 8 funds tracked by Wall St. Rank hold C.PRK as of Q3 2019.
- Fulton Breakefield Broenniman reported no remaining Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K position as of Q3 2019 after selling out during the quarter.
- Fulton Breakefield Broenniman sold 13,725 Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K shares in Q3 2019, an estimated $376K.
- Fulton Breakefield Broenniman first reported a position in Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K in Q1 2018 and held it in 6 quarters.
- Fulton Breakefield Broenniman's Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K position peaked at $379K in Q1 2019.
- 8 funds tracked by Wall St. Rank held Citigroup Inc. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 6.875% Fixed Rate/Floating Rate Noncumulative Preferred Stock, Series K as of Q3 2019.
Based on Fulton Breakefield Broenniman's 13F filing for Q3 2019, filed 17 Oct 2019.